Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Canada Trims Red Tape Around OTC Switches As Part Of Agency Cuts

This article was originally published in The Pink Sheet Daily

Executive Summary

The process of switching drugs Rx-to-OTC will be streamlined as part of the government’s budget cuts. Health Canada, which must save $200 million annually by fiscal year 2014-15, also is tweaking its regulation of natural health products.


Related Content

In Brief
Canada Natural Health Product Reg Chips Away At Application Backlog
Canadian Rx-to-OTC Approval Process Could Be Smoother, GSK Exec Says
Maximum Strength Pepcid AC Approval Calls For Postmarketing Study


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts